Yourgene Health Revenue and Competitors
Estimated Revenue & Valuation
- Yourgene Health's estimated annual revenue is currently $22.5M per year.
- Yourgene Health's estimated revenue per employee is $155,000
Employee Data
- Yourgene Health has 145 Employees.
- Yourgene Health grew their employee count by -17% last year.
Yourgene Health's People
Name | Title | Email/Phone |
---|---|---|
1 | VP Sales, Americas | Reveal Email/Phone |
2 | Production Manager | Reveal Email/Phone |
3 | Culture & Performance Manager | Reveal Email/Phone |
4 | Senior Technical Support Scientist | Reveal Email/Phone |
5 | Field Application Scientist | Reveal Email/Phone |
6 | Manufacturing Scientist | Reveal Email/Phone |
7 | Senior Regional Sales Manager | Reveal Email/Phone |
8 | Manufacturing Scientist | Reveal Email/Phone |
Yourgene Health Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.5M | 29 | -12% | N/A | N/A |
#2 | $15.7M | 101 | 5% | N/A | N/A |
#3 | $87.9M | 405 | 25% | $292M | N/A |
#4 | $2.6M | 470 | 16% | $631.7M | N/A |
#5 | $14.9M | 96 | -8% | $81M | N/A |
#6 | $44.8M | 231 | 0% | $132.9M | N/A |
#7 | $7.6M | 49 | -37% | N/A | N/A |
#8 | $17.4M | 112 | 12% | N/A | N/A |
#9 | $334.6M | 1349 | 11% | £994.6M | N/A |
#10 | $830.2M | 5356 | 8% | N/A | N/A |
What Is Yourgene Health?
Yourgene Health is an international molecular diagnostics group which develops and commercialises genetic products and services that positively impact human health. The group works in partnership with global leaders in DNA technology to advance diagnostic science. Our product development, research service and commercial capabilities extend across the lifecycle of DNA test development including regulatory submissions. Yourgene Health's first commercialised products are non-invasive prenatal tests (NIPT) for Down's syndrome and other genetic disorders, targeting a share of an emerging billion-dollar global market. Prenatal screening is an established clinical practice, but accuracy challenges with traditional methods are driving the need for NIPT and other DNA-based reproductive health testing solutions. Yourgene Health's customer-focused products and services support all types of customer, irrespective of size, geography and market maturity. Our commercial footprint is already established in the UK, Europe, the Middle East, Africa and Asia. Through our technical expertise and partnerships, Yourgene Health is aiming to extend its genetic testing offering into complementary areas of reproductive health and oncology. Yourgene Health is headquartered in Manchester, UK with offices in Taipei and Singapore. For more information visit www.yourgene-health.com and follow us on twitter @Yourgene_Health.
keywords:N/AN/A
Total Funding
145
Number of Employees
$22.5M
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Yourgene Health News
NEW YORK Yourgene Health said on Monday that it has extended its existing strategic partnership with Ambry Genetics with a new genomic...
By Sabela Ojea. Yourgene Health PLC said Tuesday that its performance for fiscal 2022 was in line with views, marked by significant revenue...
Yourgene Health PLC - Manchester-based molecular diagnostics - For the year ended March 31, revenue more than doubles year-on-year to...
Manchester, UK - 28 October 2021: Yourgene (AIM: YGEN), a leading international molecular diagnostics group, announces that its Ranger®Technology, which was acquired with Coastal Genomics Inc in August 2020, will be presented by Yourgene's strategic customer, Labcorp, at the Labroots 2021 Clinic ...
Yourgene Health plc ("Yourgene" or the "Group" or the "Company") AGM Statement Investor presentation Manchester, UK - 28 September 2021: Yourgene (AIM: YGEN), a leading international molecular diagnostic group, will be holding its Annual General Meeting (AGM) at 4:00pm today. In-person regis ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $43.1M | 145 | 34% | N/A |
#2 | $35.3M | 146 | 7% | N/A |
#3 | $43.4M | 146 | 6% | N/A |
#4 | $37.6M | 146 | 5% | N/A |
#5 | $52.6M | 147 | 21% | N/A |